Xvivo Perfusion
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
XVIVO | ST
Overview
Corporate Details
- ISIN(s):
- SE0004840718 (+1 more)
- LEI:
- 549300G2464FYLS14B41
- Country:
- Sweden
- Address:
- Gemenskapens Gata 9, 431 53 Mölndal
- Website:
- https://www.xvivogroup.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Xvivo Perfusion is a medical technology company specializing in solutions for ex-vivo organ preservation. The company develops and markets innovative systems, solutions, and services that enable clinicians and researchers to preserve, assess, and transport donated organs—including lungs, hearts, livers, and kidneys—outside the body prior to transplantation. Its core offering is centered on machine perfusion technology, which aims to increase the availability and improve the quality of viable organs. Key products include the XPS™ (Ex Vivo Lung Perfusion System), Liver Assist™, and Kidney Assist Transport™, as well as the PERFADEX® Plus preservation solution. Xvivo's technologies are designed to extend organ preservation time, enhance assessment, and ultimately improve transplant outcomes, addressing the global shortage of transplantable organs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-08 10:01 |
Major Shareholding Notification
|
Swedish | 9.5 KB | ||
| 2025-07-28 22:10 |
Legal Proceedings Report
Fördröjning i CE-godkännandeprocessen för XVIVOs perfusionslösning för hjärtpre…
|
Swedish | 64.3 KB | ||
| 2025-07-28 22:10 |
Legal Proceedings Report
Delay in CE approval for XVIVO’s perfusion solution for heart preservation
|
English | 63.6 KB | ||
| 2025-07-11 07:30 |
Interim Report
|
Swedish | 2.0 MB | ||
| 2025-07-11 07:30 |
Interim Report
|
English | 2.0 MB | ||
| 2025-04-25 14:25 |
Post-Annual General Meeting Information
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
|
Swedish | 59.6 KB | ||
| 2025-04-25 14:25 |
Post-Annual General Meeting Information
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
|
English | 60.1 KB | ||
| 2025-04-24 07:30 |
Quarterly Report
|
Swedish | 1.9 MB | ||
| 2025-04-24 07:30 |
Interim Report
|
English | 6.8 MB | ||
| 2025-03-20 17:45 |
Pre-Annual General Meeting Information
Notice to attend the annual general meeting in XVIVO Perfusion AB (publ)
|
English | 111.0 KB | ||
| 2025-03-20 17:45 |
Pre-Annual General Meeting Information
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
|
Swedish | 108.6 KB | ||
| 2025-01-28 07:30 |
Earnings Release
|
Swedish | 1.2 MB | ||
| 2025-01-28 07:30 |
Annual / Quarterly Financial Statement
|
English | 1.2 MB | ||
| 2024-12-02 10:46 |
Major Shareholding Notification
|
Swedish | 8.3 KB | ||
| 2024-10-24 07:30 |
Quarterly Report
|
Swedish | 1.2 MB |
Automate Your Workflow. Get a real-time feed of all Xvivo Perfusion filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Xvivo Perfusion via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-28 | Lena Hagman | Other | Buy | 1,500 | 466,500.00 SEK |
| 2024-11-25 | Christoffer Björn Rosenblad | Other | Sell | 2,000 | 915,000.00 SEK |
| 2024-02-29 | Kristoffer Nordström | Other | Buy | 335 | 88,440.00 SEK |
| 2023-11-14 | Gösta Johannesson | Other | Buy | 500 | 124,500.00 SEK |
| 2023-04-24 | Lars Henriksson | Other | Buy | 400 | 107,200.00 SEK |
| 2022-11-02 | Gösta Johannesson | Other | Buy | 200 | 34,000.00 SEK |
| 2022-11-01 | Gösta Johannesson | Other | Buy | 1,000 | 166,500.00 SEK |
| 2022-08-19 | Dag Andersson Tilk | Other | Buy | 499 | 99,700.20 SEK |
| 2022-05-24 | Dag Andersson Tilk | Other | Other | 5,417 | 1,115,251.96 SEK |
| 2022-05-24 | Christoffer Björn Rosenblad | Other | Other | 2,708 | 557,523.04 SEK |
/other/Spermosens_AB_publ-logo.jpg){kind=logo}
